What is Regentis Biomaterials Ltd.'s share price today?
Regentis Biomaterials Ltd. (RGNT) share price today is $1.29 as of October 27, 2026 at 12:55 AM IST. The stock touched a day high of $1.31 and a day low of $1.27.What exchange does Regentis Biomaterials Ltd. stock trade on, and under what ticker symbol?
Regentis Biomaterials Ltd. stock trades on NYSE under the ticker symbol RGNT.What is Regentis Biomaterials Ltd.'s market capitalization?
Regentis Biomaterials Ltd.'s market capitalization is $8.99M as of October 27, 2026 at 12:55 AM IST.What is Regentis Biomaterials Ltd.'s price-to-earnings (P/E) ratio?
Regentis Biomaterials Ltd.'s price-to-earnings (P/E) ratio is N/A as of October 26, 2026.What is Regentis Biomaterials Ltd.'s price-to-book (P/B) ratio?
Regentis Biomaterials Ltd.'s price-to-book (P/B) ratio is 2.57 as of October 26, 2026.Can Indian investors buy Regentis Biomaterials Ltd. shares?
Yes, You can buy Regentis Biomaterials Ltd. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Regentis Biomaterials Ltd. shares from India?
Indian investors can buy Regentis Biomaterials Ltd. shares in three steps: 1. Search Regentis Biomaterials Ltd. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Regentis Biomaterials Ltd. shares for Indian investors?
Since Regentis Biomaterials Ltd. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Regentis Biomaterials Ltd. shares via Tickertape?
Indian investors can start investing in Regentis Biomaterials Ltd. (RGNT) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 7.7101 shares at the current price of $1.29.
$
₹
$1.291.32% (+0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
2.57
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-2.46
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 1 analyst's reports
Buy1 analyst
Hold0 analyst
Sell0 analyst
Price Upside
+681.25%
Earnings Growth
—
Rev. Growth
—
Company Profile
Company Profile
P/E Ratio
85.22
85.22
1Y Return
16.85%
16.85%
Buy Reco %
85.18
85.18
P/E Ratio
50.21
50.21
1Y Return
27.73%
27.73%
Buy Reco %
93.75
93.75
P/E Ratio
21.03
21.03
1Y Return
17.86%
17.86%
Buy Reco %
29.41
29.41
P/E Ratio
26.87
26.87
1Y Return
13.61%
13.61%
Buy Reco %
50.00
50.00
P/E Ratio
24.16
24.16
1Y Return
76.59%
76.59%
Buy Reco %
20.00
20.00
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$1.28Baseline
Analyst Target - 1 year
Target$10+681.25%
All values in $
2026
Current$1.28Baseline
Analyst Target - 1 year
Target$10+681.25%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q4 2024
Q2 2025
Q4 2025
Q2 2026
Revenue
Net Income
| Financial Year | Q4 2024 | Q2 2025 | Q4 2025 | Q2 2026 |
|---|---|---|---|---|
| Total Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Net Income | - | - | - | - |
| Net Profit Margin | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareMedical Instruments & Supplies
HealthcareMedical Instruments & Supplies
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Regentis Biomaterials Ltd. | - | 2.57 | - |
| Medline Inc. Class A Common Stock | 85.22 | 2.60 | - |
| West Pharmaceutical Services Inc | 50.21 | 6.70 | 3.43 |
Price Comparison
Price Comparison
Compare RGNT with any stock or ETFCompare RGNT with any stock or ETF
Comparing from
RGNT
MDLN
WST